V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells

AIDS Research and Human Retroviruses

Volumn 12, Issue 16, 1996, Pages 1503-1507

  De Jong, Jacques ^a,e   Simon, François ^b   Van Der Groen, Guido ^c   Baan, Elly ^a   Saragosti, Sentob ^d   Brun Vézinet, Françoise ^b   Goudsmit, Jaap ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b BICHAT HOSPITAL   (France)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Hôpital Cochin ^*  (France)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS ISOLATION;

EID: 0029910803     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1503     Document Type: Article

References (28)

1. Åsjö B, Morfeldt-Månson L, Albert J, Biberfeld G, Karlsson A, Lidman K, and Fenyö E-M: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986;ii:660-662.
2. Cheng-Mayer C, Seto D, Tateno M, and Levy JA: Biologic features of HIV-1 that correlate with virulence in the host. Science 1988;240:80-82.
3. Fenyö E-M, Morfeldt-Månson L, Chiodi F, Lind B, von Gegerfelt A, Albert J, Olausson E, and Åsjö B: Distinct replicative and cytopathic characteristics of human immuno deficiency virus isolates. J Virol 1988;62:4414-4419.
4. Tersmette M, de Goede REY, Al BJM, Winkel IN, Coutinho RA, Cuypers HTM, Huisman JG, and Miedema F: Differential syncytium-inducing capacity of HIV isolates. Frequent detection of syncytium-inducing isolates in patients with AIDS and ARC. J Virol 1988;62:2026-2032.
5. Boucher CAB, Lange JMA, Miedema F, Weverling GJ, Koot M, Mulder JW, Goudsmit J, Kellam P, Larder BA, and Tersmette M: HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS 1992;6:1259-1264.
6. Koot M, Vos AHV, Keet IPM, de Goede REY, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, and Tersmette M: HIV-1 biological phenotype in long-termed infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
7. Koot M, Keet IPM, Vos AHV, de Goede REY, Roos MTL, Coutinho RA, Miedema F, Schellekens PTA, and Tersmette M: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression of AIDS. Ann Intern Med 1993;118:681-688.
8. Bergeron L, Sullivan N, and Sodroski J: Target cell-specific determinants of membrane fusion with the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J Virol 1992;66:2389-2397.
9. Freed EO, Myers DJ, and Risser R: Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J Virol 1991;65:190-194.
10. Grimaila R, Fuller BA, Rennert PD, Nelson MB, Hammerskjold M-L, Potts B, Murray M, Putney SD, and Gray G: Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol 1992;66:1875-1883.
11. Page KA, Stearns SM, and Littman DR: Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J Virol 1992;66:524-533.
12. de Jong JJ, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, and de Ronde A: Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 1992;66:757-765.
13. Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, and Schuitemaker H: Phenotype associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992; 66:3183-3187.
14. de Jong JJ, de Ronde A, Keulen W, Termsette M, and Goudsmit J: Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing (SI) phenotype: Analysis by single amino acid substitution. J Virol 1992;66:6777-6780.
15. de Wolf F, Hogervorst E, Goudsmit J, Fenyö E-M, Rübsamen-Waigmann H, Holmes H, Galvao-Castro B, Karita E, Wasi C, Sempala SDK, Baan E, Zorgdrager F, Lukashov V, Osmanov S, Kuiken C, Cornelissen M, and WHO Network for HIV Isolation and Characterization: Syncytium-inducing and non-syncytium in ducing capacity of human immunodeficiency virus type 1 subtypes other than B: Phenotypic and genotypic characteristics. AIDS Res Hum Retroviruses 1994;10:1387-1400.
16. Zhong P, Peeters M, Janssens W, Fransen K, Heyndrickx L, Vanham G, Willems B, Piot P, and van der Groen G: Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses 1995;11:239-248.
17. Holm-Hansen C, Grothues D, Rustad S, Rösok B, Pascu FR, and Åsjö B: Characterization of HIV-1 from Romanian children: Lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Res Hum Retroviruses 1995;11:597-603.
18. de Leys R, Vanderborght B, vanden Haesevelde M, Heyndrickx L, van Geel A, Wauters C, Bemaerts R, Saman E, Nijs P, Willems B, Taelman H, van der Groen G, Piot P, Tersmette M, Huisman JG, and van Heuverswyn H: Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol 1990;64:1207-1216.
19. Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, and Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-1585.
20. vanden Haesevelde M, Decourt JL, de Leys RJ, Vanderborght B, van der Groen G, van Heuverswijn H, and Saman E: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994;68: 1586-1596.
21. Chameau P, Borman AM, Quillent C, Guétard D, Chamaret S, Cohen J, Rémy G, Montagnier L, and Clavel F: Isolation and envelope sequence of a highly divergent HIV-1 isolate: Definition of a new HIV-1 group. Virology 1994;205:247-253.
22. Myers G, Korber B, Wain-Hobson S, Jeang KT, Henderson L, and Pavlakis GN: Human Retroviruses and AIDS 1994. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
23. ANT70 virus in Cameroon and Gabon. AIDS 1993; 7:1536-1537.
24. Loussert-Ajaka I, Chaix M-L, Korber B, Letourneur F, Gomas E, Allen E, Ly T-D, Brun-Vézinet F, Simon F, and Saragosti S: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-5649.
25. Kumar S, Tamura K, and Wei M: Molecular Evolutionary Genetics Analysis (MEGA), version 1.0 Institute of Molecular Evolutionary Genetics, The Pennsylvania State University, University Park, Pennsylvania, 1993.
26. Kimura M: A simple method for estimating evolutionary rates of base substitution through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111-120.
27. Forte SE, Byron KS, Sullivan JL, and Somasundaran M: Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells. AIDS Res Hum Retroviruses 1994; 10:1613-1618.
28. Milich L, Margolin B, and Swanstrom R: V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability. J Virol 1993;67:5623-5634.